We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Mylan Appeals Adverse Patent Ruling to Supreme Court
Mylan Appeals Adverse Patent Ruling to Supreme Court
Mylan Pharmaceuticals has petitioned the U.S. Supreme Court to overturn a controversial U.S. Patent and Trademark Office (USPTO) rule that allows the USPTO’s Patent Trial and Appeal Board (PTAB) to deny a patent review petition because of the progress of a parallel U.S. district court proceeding on the same patent.